Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Chiarle

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Pathologica|March 3, 2004
Role of CD30 in the maturation of thymocytes and in the pathogenesis of autoimmune diseasesR Chiarle, G Inghirami, G Palestro
Breast Cancer Research : BCR|March 16, 2001
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancerR Chiarle, M Pagano, G Inghirami
Cancer|September 1, 1994
Argyrophilic nucleolar organizer region counts predict survival in thymomaA Pich, R Chiarle, L Chiusa, et al.
Gynecologic Oncology|August 1, 1997
Pure alveolar rhabdomyosarcoma of the corpus uteri: description of a case with increased serum level of CA-125R Chiarle, L Godio, D Fusi, et al.
Oncogene|June 13, 2000
Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa)J Liu, G Prolla, A Rostagno, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2004
Expression of the CD31 antigen in normal B-cells and non Hodgkin's lymphomasA Stacchini, R Chiarle, V Antinoro, et al.
International Journal of Cancer|June 21, 1996
p53 expression and proliferative activity predict survival in non-invasive thymomasA Pich, R Chiarle, L Chiusa, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 1999
CD30 in normal and neoplastic cellsR Chiarle, A Podda, G Prolla, et al.
Leukemia|August 22, 2003
BRAF gene is not mutated in plasma cell leukemia and multiple myelomaL Bonello, C Voena, M Ladetto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathwayR Chiarle, A Podda, G Prolla, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Pathologica|March 3, 2004
Role of CD30 in the maturation of thymocytes and in the pathogenesis of autoimmune diseasesR Chiarle, G Inghirami, G Palestro
Breast Cancer Research : BCR|March 16, 2001
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancerR Chiarle, M Pagano, G Inghirami
Cancer|September 1, 1994
Argyrophilic nucleolar organizer region counts predict survival in thymomaA Pich, R Chiarle, L Chiusa, et al.
Gynecologic Oncology|August 1, 1997
Pure alveolar rhabdomyosarcoma of the corpus uteri: description of a case with increased serum level of CA-125R Chiarle, L Godio, D Fusi, et al.
Oncogene|June 13, 2000
Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DeltaBRCA1(17aa)J Liu, G Prolla, A Rostagno, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2004
Expression of the CD31 antigen in normal B-cells and non Hodgkin's lymphomasA Stacchini, R Chiarle, V Antinoro, et al.
International Journal of Cancer|June 21, 1996
p53 expression and proliferative activity predict survival in non-invasive thymomasA Pich, R Chiarle, L Chiusa, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 1999
CD30 in normal and neoplastic cellsR Chiarle, A Podda, G Prolla, et al.
Leukemia|August 22, 2003
BRAF gene is not mutated in plasma cell leukemia and multiple myelomaL Bonello, C Voena, M Ladetto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathwayR Chiarle, A Podda, G Prolla, et al.
Pageof 3